DiaMedica Therapeutics Inc.

DMAC · NASDAQ
Analyze with AI
$8.68−$0.71 (−7.56%)
At close:Dec 15, 2025, 8:59 PM UTC
$8.67−$0.01 (−0.12%)
After hours:Dec 15, 2025, 9:10 PM UTC
P/E TTM-12.61
P/B TTM13.72
P/S TTM32.75
Dividend Yield0%
EPS-$0.71
Beta1.304
Valuation
PEG Ratio1.61
FCF Yield-5.68%
EV / EBITDA-14.41
More On Valuation »
Quality
ROIC-114.64%
Gross Margin0.03%
Cash Conv. Ratio0.87
More On Quality »
Growth
Revenue 3Y CAGR–
FCF Growth-17.86%
More On Growth »
Safety
Net Debt / EBITDA0.12
Interest Coverage0.00
More On Safety »
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-66.73
More On Efficiency »

DiaMedica Therapeutics Inc. (DMAC) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is DiaMedica Therapeutics Inc. (DMAC) stock price today?

As of Dec 15, 2025, 8:59 PM UTC, DiaMedica Therapeutics Inc. (DMAC) stock is trading at $8.68. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date DMAC stock quotes for informed trading decisions.

What is DiaMedica Therapeutics Inc.'s market capitalization?

DiaMedica Therapeutics Inc. (DMAC) has a market capitalization of approximately $452.0M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare DiaMedica Therapeutics Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the DMAC stock price changes.

What is the 52-week range for DiaMedica Therapeutics Inc. stock?

DiaMedica Therapeutics Inc. (DMAC) stock has traded in a 52-week range of $3.19 — $10.42. The 52-week range shows the highest and lowest prices at which DMAC traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current DiaMedica Therapeutics Inc. stock price to this range provides context for recent price action.

How much trading volume does DiaMedica Therapeutics Inc. stock have?

DiaMedica Therapeutics Inc. (DMAC) stock recently traded approximately 673.2K shares. Trading volume indicates market liquidity and investor interest in DMAC. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting DiaMedica Therapeutics Inc. stock.

Does DiaMedica Therapeutics Inc. pay dividends to shareholders?

Yes, DiaMedica Therapeutics Inc. (DMAC) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate DiaMedica Therapeutics Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is DiaMedica Therapeutics Inc.'s intraday price range?

Today, DiaMedica Therapeutics Inc. (DMAC) stock has traded in a range of $8.40 — $9.52. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring DMAC's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get DiaMedica Therapeutics Inc. stock data?

AlphaPilot sources real-time DMAC stock quotes, fundamental financial data, and historical price charts for DiaMedica Therapeutics Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The DiaMedica Therapeutics Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of DMAC stock performance.